Biotech Market to Grow by USD 805.6 Billion (2025-2029), Boosted by Vendor Innovation, with AI Driving Market Transformation - Technavio

NEW YORK, Jan. 31, 2025 /PRNewswire/ -- Report with the AI impact on market trends - The global biotech market size is estimated to grow by USD 805.6 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of  12.4%  during the forecast period. Growing innovation by market vendors is driving market growth, with a trend towards increasing investment by market vendors. However, regulatory compliance associated with biotech  poses a challenge. Key market players include AbbVie Inc., Amgen Inc., AstraZeneca Plc, BeiGene Ltd., BioMarin Pharmaceutical Inc., BioNTech SE, CSL Ltd., F. Hoffmann La Roche Ltd., Genmab AS, Gilead Sciences Inc., Johnson and Johnson Inc., Moderna Inc., Novartis AG, Novo Nordisk AS, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., Thermo Fisher Scientific Inc., and Vertex Pharmaceuticals Inc..

Key insights into market evolution with AI-powered analysis. Explore trends, segmentation, and growth drivers- View Free Sample PDF

Market Driver

The biotech market is experiencing significant growth with trends such as genetic engineering and precision medicine leading the way. These innovations are improving health outcomes by enabling personalized treatment plans and advanced disease management. Biostatistics, proteomics, and genomic research are key areas of focus, driving medical breakthroughs in patient care. Immunotherapy, medical devices, and pharmaceutical innovation are also transforming the biopharma industry. Emerging companies in synthetic biology and cell therapy are disrupting traditional healthcare solutions, while agricultural biotechnology is delivering disease-free banana varieties and herbicide-tolerant seeds. Biotechnology education and career opportunities are expanding, with a focus on ethics and policy. Global health initiatives are investing in medical research funding, driving advancements in clinical data analysis and disease prevention. Public health and healthcare trends are converging with technology, leading to innovations in health technology, clinical trials, and disease treatment. Biotech startups and established companies are collaborating to commercialize biotechnology, with a focus on sustainability and environmental stewardship. Regulation and innovation are shaping the industry, with a growing emphasis on bioethics and biomedical research. PCR technologies and nucleic acid sequencing are revolutionizing clinical diagnostics, while gene editing and gene therapy are offering new possibilities for disease treatment. The biotech industry is a dynamic and evolving field, with endless opportunities for innovation and growth. 

The global biotech market is experiencing substantial growth, with investments increasing due to the industry's potential to tackle significant health concerns. Notably, GlycoNet announced in December 2024, committing USD4.5 million to fund 21 research projects focusing on biological sugars. This initiative is supported by additional investments from collaborators, foundations, and partners, totaling USD7.5 million. The projects' combined budget is projected to reach USD12 million over the next two years. 

Request Sample of our comprehensive report now to stay ahead in the AI-driven market evolution!

Market Challenges

• The biotech market is experiencing significant growth due to advancements in various sectors like genetic engineering, precision medicine, and health outcomes. Biostatistics, proteomics, and patient care are also driving innovation in the industry. Immunotherapy, medical devices, and pharmaceutical innovation are key areas of focus for biotech startups and the biopharma industry. Global health and healthcare solutions are benefiting from medical breakthroughs in disease management, drug discovery, and clinical trials. Biotechnology policy and education are crucial for the sustainable growth of this sector. Agricultural biotechnology, through disease-free banana varieties and herbicide-tolerant seeds, is another promising area. Synthetic biology and cell therapy are emerging trends in biotech. Biotechnology careers are on the rise, with opportunities in data management, regulatory affairs, and biotechnology ethics. Investment in biotech is growing, fueled by the potential for biotechnology patents and innovation. Biotechnology applications span from healthcare to agriculture, and the industry continues to push boundaries in areas like gene editing and nucleic acid sequencing. Clinical data analysis, disease prevention, and medical research funding are essential for advancing healthcare trends. Overall, biotech is a dynamic and innovative industry that is transforming healthcare, agriculture, and the environment.
• The biotech industry faces a substantial challenge in ensuring regulatory compliance. Companies in this sector must keep updated with the latest regulations and guidelines issued by regulatory bodies like the FDA, EMA, and others. Understanding these requirements is vital for maintaining compliance and ensuring the safety and efficacy of biotech products. To navigate this intricate regulatory landscape, biotechnology firms need to establish quality control systems. These systems should incorporate thorough quality assurance procedures, process validation, and rigorous documentation practices. Ensuring that all processes align with regulatory standards is crucial for preventing compliance issues and safeguarding the integrity of the companies' operations.

Discover how AI is revolutionizing market trends- Get your access now!

Segment Overview 

This biotech market report extensively covers market segmentation by  

• 1.1 Biologics
• 1.2 Therapeutics
• 1.3 Diagnostics
• 1.4 Industrial biotechnology
• 1.5 Others

• 2.1 Red biotechnology
• 2.2 White biotechnology
• 2.3 Green biotechnology
• 2.4 Grey biotechnology
• 2.5 Others

• 3.1 North America
• 3.2 Europe
• 3.3 Asia
• 3.4 Rest of World (ROW)

1.1 Biologics-  The biotech market is divided into several product categories, with biologics being a substantial and rapidly expanding segment. Biologics, comprised of monoclonal antibodies, vaccines, recombinant proteins, and cell and gene therapies, are derived from living organisms and address a diverse range of diseases, including cancer, autoimmune disorders, and genetic conditions. In August 2023, Novartis finalized its acquisition of Chinook Therapeutics, Inc., a biopharmaceutical company specializing in precision medicines for kidney diseases, valued at up to USD3.5 billion. This acquisition bolsters Novartis' biologics portfolio, particularly in precision medicine, which is gaining importance for disease-specific treatments and enhanced patient outcomes. In September 2023, Evotec SE entered into a technology development partnership with Novo Nordisk to advance cell therapy. Both companies contribute significant expertise and strategic focus to stem cell-based therapies, aiming to create next-generation off-the-shelf cell therapy products for clinical development and potential commercialization. The biologics market is fueled by factors such as the increasing prevalence of chronic diseases, advancements in biotechnology, and rising research and development investments. Personalized medicine and targeted therapies are emerging trends, offering better efficacy and fewer side effects compared to traditional treatments. Additionally, the approval of new biologics and biosimilars is expanding the market, providing more treatment options for patients and intensifying competition among biotech companies.

Download a Sample of our comprehensive report today to discover how AI-driven innovations are reshaping competitive dynamics

Research Analysis

Biotech market continues to evolve, driven by advancements in biology and technology. Derivatives from HIV and other organisms are revolutionizing medicine, with clinical success stories in treating neurological disorders, cancer, and infectious diseases like malaria. Global investments in biotech are on the rise, fueled by positive outcomes and enhanced reimbursement policies. Obesity and diabetes are major focus areas, with innovative companies engineering solutions for environmental sustainability. Engineering regeneration technologies for biological systems holds great promise for society. Bio-pharmaceutical companies are pioneering personalized medicine, while tissue culture technology advances approval processes for cell therapies. Gene therapies and molecular breeding are transforming plant varieties, and cloning and gene editing technologies are pushing the boundaries of science. The market revenue for biotech is projected to grow significantly, driven by the potential of biotechnology applications in various industries. The conventional treatment plan is being replaced by a more sustainable, science-driven approach.

Market Research Overview

Biotechnology is a dynamic and innovative industry that leverages advanced technologies to improve health outcomes, drive medical breakthroughs, and address global health challenges. Precision medicine, genetic engineering, and genomics are key areas of focus, enabling personalized treatments and disease prevention. Proteomics, immunotherapy, and cell therapy are revolutionizing disease treatment, while medical devices and health technology are enhancing patient care. Biostatistics and clinical data analysis are essential for drug discovery and clinical trials. Pharmaceutical innovation, biotech startups, and biopharma industry are at the forefront of creating healthcare solutions, from medical research funding to public health initiatives. Biotechnology advancements in agriculture, such as disease-free banana varieties and herbicide-tolerant seeds, are also making a significant impact. Synthetic biology, genome editing, and bioethics are shaping the future of this rapidly evolving field. Biotechnology careers span various sectors, from research and development to policy and regulation. Education, investment, and innovation are critical to driving progress in this industry, which continues to transform healthcare and sustainability.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

• Product
• Biologics
• Therapeutics
• Diagnostics
• Industrial Biotechnology
• Others
• Type
• Red Biotechnology
• White Biotechnology
• Green Biotechnology
• Grey Biotechnology
• Others
• Geography
• North America
• Europe
• Asia
• Rest Of World (ROW)

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/biotech-market-to-grow-by-usd-805-6-billion-2025-2029-boosted-by-vendor-innovation-with-ai-driving-market-transformation---technavio-302364467.html

SOURCE Technavio